BRET2: Efficient energy transfer from renilla luciferase to GFP2 to measure protein-protein interactions and intracellular signaling events in live cells

Luminescence Biotechnology: Instruments and Applications

Volumn , Issue , 2001, Pages 539-555

  Dionne, Pierre ^a   Caron, Mireille ^a   Labonté, Anne ^a   Carter Allen, Kelly ^b   Houle, Benoit ^a   Joly, Erik ^a   Taylor, Sean C ^a   Menard, Luc ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b Packard BioScience   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57849162495     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420041804     Document Type: Chapter

References (18)

1. Xu, Y., Piston, D. W., and Johnson, C. H., A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins, Proc. Natl. Acad. Sci. U.S.A., 96, 151-156, 1999.
2. Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M., and Bouvier, M., Detection of β2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET), Proc. Natl. Acad. Sci. U.S.A., 97, 3684-3689, 2000.
3. Watson, S. and Arkinstall, S., The G-Protein Linked Receptor Facts Book, Academic Press, San Diego, CA, 1994.
4. Neer, E. J., Heterotrimeric G proteins: organizers of transmembrane signals, Cell, 80, 249-257, 1995.
5. Lefkowitz, R. J., G protein-coupled receptors; III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization, J. Biol. Chem., 273, 18,677-18,680, 1998.
6. Ferguson, S. G. S., Barak, L. S., Zhang, J., and Caron, M. G., G-protein-coupled receptor regulation:role of G-protein-coupled receptor kinases and arrestins, Can. J. Physiol. Pharmacol., 74, 1095-1110, 1996.
7. Cao, W., Luttrell, L. M., Medvedev, A. V., Pierce, K. L., Daniel, K. W., Dixon, T. M., Lefkowitz, R. J., and Collins, S., Direct binding of activated c-src to the β3-adrenergic receptor is required for MAP kinase activation, J. Biol. Chem., 275, 38,131-38,134, 2000.
8. Chidiac, P., Hebert, T. E., Valiquette, M., Dennis, M., and Bouvier, M., Inverse agonist activity of β-adrenergic antagonists, Mol. Pharmacol., 45, 490-499, 1994.
9. Nichelson, D. W. and Thornberry, N. A., Caspases: killer proteases, Trends Biol. Sci., 22, 299-306, 1997.
10. Thornberry, N. A. and Lazebnik, Y., Caspases: enemies within, Science, 281, 1312-1316, 1998.
11. Villa, P., Kaufmann, S. H., and Earnshaw, W. C., Caspases and caspase inhibitors, TIBS, 22, 388-393, 1997.
12. Talanian, R. V., Quinlan, C., Trautz, S., Hackett, M. C., Mankovich, J. A., Banach, D., Ghayur, T., Brady, K. D., and Wong, W. W., Substrate specificities of caspase family proteases, J. Biol. Chem., 272, 9677-9682, 1997.
13. Shinbrot, E., Spencer, C. M., and Kain, S. R., Morphological detection of plasma membrane changes during apoptosis using enhanced green fluorescent protein, BioTechniques, 26, 1065-1067, 1999.
14. Margolin, N., Raybuck, S. A., Wilson, K. P., Chen, W., Fox, T., Gu, Y., and Livingston, D. J., Substrate and inhibitor specificity of interleukin-1 beta-converting enzyme, J. Biol. Chem., 272, 7223-7228, 1997.
15. Jones, J., Heim, R., Hare, E., Stack, J., and Pollok, B. A., Development and application of a GFPFRET intracellular caspase assay for drug screening, J. Biomol. Screening, 5, 307-317, 2000.
16. Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W., Funke, R., Gage, D., Harris, K., Heaford, A., Howland, J., Kann, L., Lehoczky, J., LeVine, R., McEwan, P., McKernan, K., Meldrim, J., Mesirov, J. P., Miranda, C., Morris, W., Naylor, J., Raymond, C., Rosetti, M., Santos, R., Sheridan, A., Sougnez, C., Stange-Thomann, N., Stojanovic, N., Subramanian, A., Wyman, D., Rogers, J., Sulston, J., Ainscough, R., Beck, S., Bentley, D., Burton, J., Clee, C., Carter, N., Coulson, A., Deadman, R., Deloukas, P., Dunham, A., Dunham, I., Durbin, R., French, L., Grafham, D., Gregory, S., Hubbard, T., Humphray, S., Hunt, A., Jones, M., Lloyd, C., McMurray, A., Matthews, L., Mercer, S., Milne, S., Mullikin, J. C., Mungall, A., Plumb, R., Ross, M., Shownkeen, R., Sims, S., Waterston, R. H., Wilson, R. K., Hillier, L. W., McPherson, J. D., Marra, M. A., Mardis, E. R., Fulton, L. A., Chinwalla, A. T., Pepin, K. H., Gish, W. R., Chissoe, S. L., Wendl, M. C., Delehaunty, K. D., Miner, T. L., Delehaunty, A., Kramer, J. B., Cook, L. L., Fulton, R. S., Johnson, D. L., Minx, P. J., Clifton, S. W., Hawkins, T., Branscomb, E., Predki, P., Richardson, P., Wenning, S., Slezak, T., Doggett, N., Cheng, J. F., Olsen, A., Lucas, S., Elkin, C., Uberbacher, E., Frazier, M. et al., Initial sequencing and analysis of the human genome, Nature, 409, 860-921, 2001.
17. Blackstock, W. P. and Weir, M. P., Proteomics: quantitative and physical mapping of cellular proteins, Trends Biotechnol., 17, 121-127, 1999.
18. Yates III, J. R., Mass spectrometry. From genomics to proteomics, Trends Genet., 16, 5-8, 2000.